methotrexate prefilled pen

DEVICE2 trials

Sponsors

medac GmbH

Conditions

Juvenile Idiopathic ArthritisRheumatoid Arthritis

Early Phase 1

Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis

CompletedNCT02052167

medac GmbHJuvenile Idiopathic Arthritis

Start: 2014-04-30End: 2014-08-31Updated: 2018-03-29

Phase 3

Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)

CompletedNCT01793259

medac GmbHRheumatoid Arthritis

Start: 2012-07-31End: 2013-06-30Updated: 2013-07-15

Related Papers

Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.

2014-08-0640 citations